CRISPR-Cas9 Toolkit for Actinomycete Genome Editing.

Area of Science:

• Microbiology
• Molecular Biology
• Biotechnology

Background:

• Actinomycetales bacteria are crucial sources of bioactive natural products and drugs.
• Limited genome editing tools hinder metabolic engineering in many Actinomycetales strains.
• Efficient genetic manipulation is essential for optimizing natural product yields and discovering new compounds.

Purpose of the Study:

• To develop a versatile and efficient CRISPR-Cas9 toolkit for genome editing in Actinomycetales.
• To enable systematic metabolic engineering for enhanced natural product discovery and production.
• To overcome existing limitations in genetic manipulation of these important bacteria.

Main Methods:

• Development of a CRISPR-Cas9 toolkit including software for sgRNA identification.
• Implementation of systems for in-frame gene/gene cluster knockout and gene loss-of-function studies.
• Adaptation of uracil-specific excision reagent (USER) cloning for simplified vector construction and gene knockdown.

Main Results:

• The toolkit demonstrated high efficiency in genome editing of Actinomycetales.
• Successfully applied for perturbation of Streptomyces coelicolor A3(2) and Streptomyces collinus Tü 365 genomes.
• Enabled gene knockout, gene knockdown, and random deletion library generation.

Conclusions:

• The developed CRISPR-Cas9 toolkit significantly advances genome editing capabilities for Actinomycetales.
• This toolkit provides a robust platform for metabolic engineering to boost natural product biosynthesis.
• Facilitates broader research into Actinomycetales, aiding drug discovery and development.